Ines Laviada-Diaz
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Proteomic profiling reveals that DPP4 overexpression increases cell adhesion, inhibits cell migration, and restores androgen sensitivity in prostate cancer.
Journal: Bioscience reports
Published: January 15, 2026
Tuning chemical properties on ruthenium(II) complexes through PEGylation of N-heterocyclic carbene ligands.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: January 05, 2026
TRPV1 Downregulation Impairs Prostate Cancer Growth: Functional and Translational Insights from Cellular and In Vivo Models.
Journal: International journal of biological sciences
Published: September 18, 2025
Ruthenium(II) complexes containing PEGylated N-heterocyclic carbene ligands for tunning biocompatibility in the fight against cancer.
Journal: Journal of inorganic biochemistry
Published: July 31, 2024
Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications.
Journal: International journal of molecular sciences
Published: August 20, 2023
Alteration of the HIF-1α/VEGF Signaling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers.
Journal: Biomacromolecules
Published: November 29, 2022
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology.
Journal: Biomedicines
Published: July 29, 2022
Metabolic fingerprinting of chemotherapy-resistant prostate cancer stem cells. An untargeted metabolomic approach by liquid chromatography-mass spectrometry.
Journal: Frontiers in cell and developmental biology
Published: July 28, 2022
Increase in Ischemia-Modified Albumin and Pregnancy-Associated Plasma Protein-A in COVID-19 Patients.
Journal: Journal of clinical medicine
Published: September 24, 2021
Last Updated: 09/26/2026